Role of mTOR in Glucose and Lipid Metabolism.
Zhuo MaoWeizhen ZhangPublished in: International journal of molecular sciences (2018)
The mammalian target of rapamycin, mTOR is the master regulator of a cell's growth and metabolic state in response to nutrients, growth factors and many extracellular cues. Its dysregulation leads to a number of metabolic pathological conditions, including obesity and type 2 diabetes. Here, we review recent findings on the role of mTOR in major metabolic organs, such as adipose tissues, liver, muscle, pancreas and brain. And their potentials as the mTOR related pharmacological targets will be also discussed.
Keyphrases
- type diabetes
- cell proliferation
- insulin resistance
- metabolic syndrome
- gene expression
- skeletal muscle
- weight loss
- cardiovascular disease
- single cell
- adipose tissue
- white matter
- transcription factor
- cell therapy
- stem cells
- glycemic control
- blood pressure
- blood glucose
- multiple sclerosis
- fatty acid
- resting state
- drug induced
- cerebral ischemia